These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1235 related articles for article (PubMed ID: 24696072)

  • 1. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mesenchymal stem cells from human cord blood promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice].
    Zhou DH; Huang SL; Huang K; Wu YF; Bao R; Wei J; Zhang XC; Li Y
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):732-5. PubMed ID: 16620577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stromal cell supported umbilical cord blood ex vivo expansion enhances regulatory T cells and reduces graft versus host disease.
    Fan X; Gay FP; Ong SY; Ang JM; Chu PP; Bari S; Lim TK; Hwang WY
    Cytotherapy; 2013 May; 15(5):610-9. PubMed ID: 23419678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of MSC coadministration and route of delivery on cord blood hematopoietic stem cell engraftment.
    Carrancio S; Romo C; Ramos T; Lopez-Holgado N; Muntion S; Prins HJ; Martens AC; Briñón JG; San Miguel JF; Del Cañizo MC; Sanchez-Guijo F
    Cell Transplant; 2013; 22(7):1171-83. PubMed ID: 23031585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hematopoietic reconstitution by co-transplantation of human BM-MSCs and UCB CD34+ cells at various times in NOD/SCID mice].
    Ma LJ; Hu XX; Zhou H; Gao L; Qiu HY; Wang JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):355-9. PubMed ID: 18426664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
    Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells.
    Delalat B; Pourfathollah AA; Soleimani M; Mozdarani H; Ghaemi SR; Movassaghpour AA; Kaviani S
    Hematology; 2009 Jun; 14(3):125-32. PubMed ID: 19490756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.
    Bari S; Chu PP; Lim A; Fan X; Gay FP; Bunte RM; Lim TK; Li S; Chiu GN; Hwang WY
    Nanomedicine; 2013 Nov; 9(8):1304-16. PubMed ID: 23732300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-transplantation of third-party umbilical cord blood-derived MSCs promotes engraftment in children undergoing unrelated umbilical cord blood transplantation.
    Lee SH; Lee MW; Yoo KH; Kim DS; Son MH; Sung KW; Cheuh H; Choi SJ; Oh W; Yang YS; Koo HH
    Bone Marrow Transplant; 2013 Aug; 48(8):1040-5. PubMed ID: 23396407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study.
    Liu X; Wu M; Peng Y; Chen X; Sun J; Huang F; Fan Z; Zhou H; Wu X; Yu G; Zhang X; Li Y; Xiao Y; Song C; Xiang AP; Liu Q
    Cell Transplant; 2014; 23(9):1087-98. PubMed ID: 23294601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiment study of efficacy on hematopoietic reconstitution and GVHD prophylaxis after mesenchymal cell infused by intra-bone marrow cavity or intravenous in rat BMT models].
    Huang K; Huang SL; Zhou DH; Cai Y; Zhang XC; Li Y
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):87-92. PubMed ID: 17650667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.
    Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY
    Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
    Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
    Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of lentiviral vector mediated CXCR4 gene overexpressed mesenchymal stem cell on the protection of mice against graft-versus-host disease].
    Chen W; Li M; Zhang C; Wang X; Pan B; Zeng L; Li Z; Xu K
    Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):936-40. PubMed ID: 25339334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.